Trans-Nerolidol

Trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) (HY-15142A) against intestinal cancer and breast cancer cells in vitro. trans-Nerolidol increases accumulation of DOX inside cells in vitro. trans-Nerolidol activates apoptosis in vivo[1].

Product Specifications

CAS Number

[40716-66-3]

UNSPSC

12352211

Hazard Statement

H317, H319, H410

Target

Fungal

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/trans-nerolidol.html

Purity

97.58

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C=CC(C)(O)CC/C=C(C)/CC/C=C(C)/C

Molecular Formula

C15H26O

Molecular Weight

222.37

Precautions

H317, H319, H410

References & Citations

[1]Hanušová V, et al. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed Pharmacother. 2017 Nov;95:828-836.